11206 related articles for article (PubMed ID: 26469747)
1. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
2. Opioid Prescribing Behaviors - Prescription Behavior Surveillance System, 11 States, 2010-2016.
Strickler GK; Kreiner PW; Halpin JF; Doyle E; Paulozzi LJ
MMWR Surveill Summ; 2020 Jan; 69(1):1-14. PubMed ID: 31999681
[TBL] [Abstract][Full Text] [Related]
3. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.
Rutkow L; Chang HY; Daubresse M; Webster DW; Stuart EA; Alexander GC
JAMA Intern Med; 2015 Oct; 175(10):1642-9. PubMed ID: 26280092
[TBL] [Abstract][Full Text] [Related]
4. Vital Signs: Changes in Opioid Prescribing in the United States, 2006-2015.
Guy GP; Zhang K; Bohm MK; Losby J; Lewis B; Young R; Murphy LB; Dowell D
MMWR Morb Mortal Wkly Rep; 2017 Jul; 66(26):697-704. PubMed ID: 28683056
[TBL] [Abstract][Full Text] [Related]
5. High-risk use by patients prescribed opioids for pain and its role in overdose deaths.
Gwira Baumblatt JA; Wiedeman C; Dunn JR; Schaffner W; Paulozzi LJ; Jones TF
JAMA Intern Med; 2014 May; 174(5):796-801. PubMed ID: 24589873
[TBL] [Abstract][Full Text] [Related]
6. Prescribing of Opioids and Benzodiazepines Among Patients With History of Overdose.
Griggs C; Wyatt S; Wally MK; Runyon M; Hsu JR; Seymour RB; Beuhler M; Bosse MJ; Fogg R; Gibbs M; Haas E; Jarrett S; Leas D; Saha A; Schiro S; Watling B;
J Addict Med; 2019; 13(5):396-402. PubMed ID: 30844876
[TBL] [Abstract][Full Text] [Related]
7. Changes in opioid prescribing after implementation of mandatory registration and proactive reports within California's prescription drug monitoring program.
Castillo-Carniglia A; González-Santa Cruz A; Cerdá M; Delcher C; Shev AB; Wintemute GJ; Henry SG
Drug Alcohol Depend; 2021 Jan; 218():108405. PubMed ID: 33234299
[TBL] [Abstract][Full Text] [Related]
8. Variation among states in prescribing of opioid pain relievers and benzodiazepines--United States, 2012.
Paulozzi LJ; Mack KA; Hockenberry JM
J Safety Res; 2014 Dec; 51():125-9. PubMed ID: 25453186
[TBL] [Abstract][Full Text] [Related]
9. Trends and Patterns of Geographic Variation in Opioid Prescribing Practices by State, United States, 2006-2017.
Schieber LZ; Guy GP; Seth P; Young R; Mattson CL; Mikosz CA; Schieber RA
JAMA Netw Open; 2019 Mar; 2(3):e190665. PubMed ID: 30874783
[TBL] [Abstract][Full Text] [Related]
10. An Examination of Concurrent Opioid and Benzodiazepine Prescribing in 9 States, 2015.
Guy GP; Zhang K; Halpin J; Sargent W
Am J Prev Med; 2019 Nov; 57(5):629-636. PubMed ID: 31564606
[TBL] [Abstract][Full Text] [Related]
11. State Legal Restrictions and Prescription-Opioid Use among Disabled Adults.
Meara E; Horwitz JR; Powell W; McClelland L; Zhou W; O'Malley AJ; Morden NE
N Engl J Med; 2016 Jul; 375(1):44-53. PubMed ID: 27332619
[TBL] [Abstract][Full Text] [Related]
12. The effects of state rules on opioid prescribing in Indiana.
Al Achkar M; Grannis S; Revere D; MacKie P; Howard M; Gupta S
BMC Health Serv Res; 2018 Jan; 18(1):29. PubMed ID: 29347984
[TBL] [Abstract][Full Text] [Related]
13. Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines.
Manders L; Abd-Elsayed A
Pain Physician; 2020 Jun; 23(3):299-304. PubMed ID: 32517396
[TBL] [Abstract][Full Text] [Related]
14. The Supply of Prescription Opioids: Contributions of Episodic-Care Prescribers and High-Quantity Prescribers.
Schneberk T; Raffetto B; Kim D; Schriger DL
Ann Emerg Med; 2018 Jun; 71(6):668-673.e3. PubMed ID: 29275945
[TBL] [Abstract][Full Text] [Related]
15. Effect of Controlled Substance Use Management on Prescribing Patterns and Health Outcomes Among High-Risk Users.
Chen X; Ma Q; Barron J; DeVries A; Horn J; Agiro A
J Manag Care Spec Pharm; 2019 Mar; 25(3):392-401. PubMed ID: 30816820
[TBL] [Abstract][Full Text] [Related]
16. Opioid Prescribing Patterns and Patient Outcomes by Prescriber Type in the Oregon Prescription Drug Monitoring Program.
Fink PB; Deyo RA; Hallvik SE; Hildebran C
Pain Med; 2018 Dec; 19(12):2481-2486. PubMed ID: 29155988
[TBL] [Abstract][Full Text] [Related]
17. The Concentration of Opioid Prescriptions by Providers and Among Patients in the Oregon Medicaid Program.
Kim H; Hartung DM; Jacob RL; McCarty D; McConnell KJ
Psychiatr Serv; 2016 Apr; 67(4):397-404. PubMed ID: 26766755
[TBL] [Abstract][Full Text] [Related]
18. Assisted Reproductive Technology Surveillance — United States, 2012.
Sunderam S; Kissin DM; Crawford SB; Folger SG; Jamieson DJ; Warner L; Barfield WD;
MMWR Surveill Summ; 2015 Aug; 64(6):1-29. PubMed ID: 26270152
[TBL] [Abstract][Full Text] [Related]
19. Validation of prescriber risk indicators obtained from prescription drug monitoring program data.
Kreiner PW; Strickler GK; Undurraga EA; Torres ME; Nikitin RV; Rogers A
Drug Alcohol Depend; 2017 Apr; 173 Suppl 1():S31-S38. PubMed ID: 28363317
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
